Chimeric antigen receptor T‐cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Chimeric antigen receptor T‐cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia

Published:2020-10-03 Issue:1 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Moskop Amy¹^ORCID,Pommert Lauren²³,Thakrar Pooja⁴,Talano Julie¹,Phelan Rachel¹

Affiliation:

1. Department of Pediatrics Division of Hematology/Oncology/Blood and Marrow Transplantation Medical College of Wisconsin and Children's Wisconsin Milwaukee WI

2. Division of Oncology Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center Cincinnati OH

3. Department of Pediatrics University of Cincinnati College of Medicine Cincinnati OH

4. Department of Pediatric Radiology Medical College of Wisconsin and Children's Wisconsin Milwaukee WI

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28739

Reference32 articles.

1. How I treat relapsed childhood acute lymphoblastic leukemia

2. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

3. Updates in the biology and therapy for infant acute lymphoblastic leukemia

4. How I treat infant leukemia

5. Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy;Expert Review of Clinical Immunology;2024-05-14

2. Leukapheresis and Tisagenlecleucel Manufacturing Outcomes in Patients Age <3 Years with Relapsed/Refractory Acute Lymphoblastic Leukemia;Transplantation and Cellular Therapy;2023-09

3. Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia;New England Journal of Medicine;2023-04-27

4. The Evolution of Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukemia;Biomedicines;2022-09-14

5. Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing;Cytotherapy;2022-09